14 of 126 unique stocks in common · Jaccard: 11.1%
A weighted portfolio overlap of 24.22% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹24.22 is allocated to the exact same companies at the same relative proportions. The schemes share 14 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 4.96% in DSP Multicap Fund and 6.73% in ICICI Prudential India Opportunities Fund. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in DSP | in ICICI |
|---|---|---|
| HDFC BankBanks | 4.96% | 6.73% |
| Axis BankBanks | 4.06% | 4.88% |
| ICICI BankBanks | 3.83% | 5.33% |
| ICICI Lombard General Insurance CompanyInsurance | 2.80% | 1.86% |
| Gland PharmaPharmaceuticals & Biotechnology | 2.20% | 1.80% |
| CoforgeIT - Software | 2.39% | 1.56% |
| Mahindra & MahindraAutomobiles | 1.56% | 2.43% |
| Info Edge (India)Retailing | 1.18% | 1.80% |
| NTPCPower | 1.10% | 2.03% |
| ICICI Prudential Life Insurance CompanyInsurance | 1.99% | 0.74% |
| Hindustan AeronauticsAerospace & Defense | 0.71% | 0.80% |
| CiplaPharmaceuticals & Biotechnology | 2.38% | 0.41% |
| Cohance LifesciencesPharmaceuticals & Biotechnology | 1.06% | 0.28% |
| CyientIT - Services | 1.34% | 0.17% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.